Trials / Completed
CompletedNCT00702091
Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Ramipril 10 mg capsules under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramipril | 10 mg capsule |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2005-01-01
- Completion
- 2005-01-01
- First posted
- 2008-06-20
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00702091. Inclusion in this directory is not an endorsement.